Because of the high risk, substantial cost and slow pace of new drug discovery and
development, drug repurposing (also called repositioning, redirecting, reprofiling) is …

The SARS-CoV-2 pandemic is considered as one of the most disastrous pandemics for
human health and the world economy. RNA-dependent RNA polymerase (RdRp) is one of …

The main (Mpro) and papain-like (PLpro) proteases are highly conserved viral proteins
essential for replication of the COVID-19 virus, SARS-COV-2. Therefore, a logical plan for …

Abstract For coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), 15–30% of patients are likely to develop COVID-19 …

Abstract The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), has prompted great interest in novel …

Despite ongoing public health measures and increasing vaccination rates, deaths and
disease severity caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

Highlights•The advancement of drug repurposing (DR) relies on scientific leadership and
innovative institutions with access to knowledge.•A bibliometric review and a social network …

Glioblastoma Multiforme (GBM) is known to be by far the most aggressive brain tumor to
affect adults. The median survival rate of GBM patient's is< 15 months, while the GBM cells …

Favipiravir and remdesivir have been included in the COVID-19 treatment guidelines panel
of several countries. The main objective of the current work is to develop the first validated …

Viruses constitute a constant threat to global health and have caused millions of human and
animal deaths throughout human history. Despite advances in the discovery of antiviral …